Fractalkine gene receptor polymorphism in patients with multiple sclerosis

International Journal of Neuroscience

Volumn 123, Issue 1, 2012, Pages 31-37

  Arli, Berna ^a   Irkec, Ceyla ^a   Menevse, Sevda ^a   Yilmaz, Akin ^a   Alp, Ebru ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

CX3CR1 gene; Fractalkine gene polymorphism; Immunopathogenesis; Multiple sclerosis; T280M fractalkine receptor haplotype; V294I fractalkine receptor haplotype

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1;

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; DNA EXTRACTION; DNA POLYMORPHISM; EXPANDED DISABILITY STATUS SCALE; GENE AMPLIFICATION; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION;

EID: 84871397707     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.723079     Document Type: Article

References (22)

1. Bugeja MJ, Booth DR, Bennetts BH, Heard RN, Stewart GJ. An investigation of polymorphisms in the 4q1 3.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis. Mult Scler. 2006;12(6):710-22.
2. Greve B, Simonenko R, Illes Z, Peterfalvi A, Hamdi N, Mycko MP, Selmaj KW, Rozsa C, Rajczy K, Bauer P, Berger K, Weissert R. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland. Mult. Scler. 2008;14(2):153-58
3. Kamali-Sarvestani E, Nikseresht AR, Aliparasti MR, Vessal M. IL-8(-251A/T) and CXCR2(+1208 C/T gene polymorphisms and risk of multiple sclerosis in Iranian patients. Neurosci Lett. 2006;404(1-2):159-62.
4. Broux B, Pannemans K, Zhang X, Markovic-Plese S, Broekmans T, Eijnde BO, Van Wijmeersch B, Somers V, Geusens P, van der Pol S, van Horssen J, Stinissen P, Hellings N. CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients. Autoimmun. 2012;38(1):10-9. Epub 2011, Nov 26
5. Stojković L, Djurić T, Stanković A, Dinčić E, Stančić O, Veljković N, Alavantić D, Zivković M. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis. J Neuroimmunol. 2012;245(1-2):87-92. Epub 2012, Jan 18.
6. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR, Ransohoff RM. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci. 2006;9(7):917-24.
7. Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Fol-cik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederik-sen JL, Ransohoff RM. Expression of specifc chemokines and chemokine receptors in the central nervous system of multiple sclerosis patient. J Clin Invest. 1999;103(6):807-15
8. Qu W, Hashimoto SI, Shimada A, Nakatani Y, Ichikawa K, Saito TL, Ogoshi K, Matsushima K, Suzuk Y, Sugano S, Takeda H, Morishita S. Genome-wide genetic variations are highly correlated with proximal DNA methylation patterns. Genome Res. 2012;22(8):1419-25.
9. Klotz L, Gold R, Hemmer B, Korn T, Zipp F, Hohlfeld R, Kieseier BC, Wiendl H. Diagnosis of multiple sclerosis 2010 revision of the McDonald criteria. Nervenarzt. 2011;82(10):1302-9.
10. Sirois-Gagnon D, Chamberland A, Perron S, Brisson D, Gaudet D, Laprise C. Association of common polymorphism in the fractalkine receptor(CX3CR1) with obesity. Obesity (Silver Spring). 2011;19(1):222-7
11. Kimouli M, Miyakis S, Georgakopoulos P, Neofytou E, Achimastos AD, Spandidos DA. Polymorphisms of fractalkine receptor CX3CR1 gene in patients with symptomatic and asymptomatic carotid artery stenosis. J Atheroscler Thromb. 2009;16(5):604-10
12. Debette S, Bevan S, Dartigues JF, Sitzer M, Lorenz M, Ducimetière P, Amouyel P, Markus HS. Fractalkine recep-tor/ligand genetic variants and carotid intima-media thickness. Stroke. 2009;40(6):2212-4.
13. Dimberg J, Dienus O, Lalfgren S, Hugander A, Wagsater D. Polymorphism of fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients. Int J Col-orectal Dis. 2007;22(10):1195-2000.
14. Amanatidou V, Sourvinos G, Apostolakis S, Tsilimigaki A, Spandidos DA. T 280 M variations of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J. 2006;25(5):410-4.
15. Apostolakis S, Amanatidou V, Papadakis EG, Spendidos DA. Genetic diversity of CX3CR1 gene and coronary artery disease: new insights through a meta-analysis. Atherosclerosis. 2009;207(1):8-15.
16. Hattori H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N. T280 M and V2491 polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease. Neu-rosci Lett. 2005;374(2):132-5.
17. Lundmark F, Salter H, Hillert J. An association study of two functional promotor polymorphism in the myeloperoxidase gene in multipl sclerosis. Mult. Scler. 2007;13(6):687-700.
18. Kamali-Sarvestani E, Nikseresht AR, Afaki E, Sarvari J, Gharesi-Fard B. TNFalpha, TNF-beta and IL-4 gene polymorphisms in Iranian patients with multiple sclerosis. Acta Neurol Scand. 2007;115(3):161-6
19. Martinez A, de las Heras V, Mas Fontao A, Bartolome M, de la Concha EG, Urcelay E, Arroyo R. An IFNG polymorphism is associated with interferon-beta response in Spanish MS patients. J Neuroimmunol. 2006;173(1-2):196-9.
20. Kikuchi S, Miyagishi R, Fukazawa T, Yabe I. TNF related apoptosis induced ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunl. 2005;167(12):170-4.
21. Gade-Andovolu R, Comings DE, MacMurray J, Vuthoori RK, Tourtellotte WW, Nagra RM, Cone LA. RANTES: a genetic risk marker for multiple sclerosis. Mult Scler. 2004;10(5): 536-9
22. Djurik T, Zivkovic M, Stankovic A, Dincic E, Raicevic R, Alavantic D. Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia. J Neurol Sci. 2008;267(1-2):62-5.